export const guidelines = {
  id: 'guidelines',
  title: 'Guidelines',
  subsections: {
    keySources: {
      title: 'Key Sources',
      content: 'The following summarized guidelines for the evaluation and management of hypertrophic cardiomyopathy are prepared by our editorial team based on guidelines from the American Medical Society for Sports Medicine (AMSSM/SCMR/AHA/HRS/ACC/PACES 2024), the Heart Rhythm Society (HRS 2024), the Society of Cardiovascular Computed Tomography (SCCT/SVM/SCMR/SCA/AHA/ASNC/HRS/ACC/ACS 2024), the European Society of Cardiology (ESC 2023,2022,2018,2014), and the American Heart Association (AHA/HRS/ACC 2019,2018). ¹ ² ³ ⁴ ⁵ ⁶ ⁷ ⁸ ⁹ ¹⁰ ¹¹ ¹²',
      guidelines: [
        'AMSSM/SCMR/AHA/HRS/ACC/PACES 2024',
        'HRS 2024', 
        'SCCT/SVM/SCMR/SCA/AHA/ASNC/HRS/ACC/ACS 2024',
        'ESC 2023',
        'ESC 2022',
        'ESC 2018',
        'ESC 2014',
        'AHA/HRS/ACC 2019',
        'AHA/HRS/ACC 2018'
      ]
    }
  }
}; 